$3.08 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 226 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ACIU | Exit | AC IMMUNE SA | $0 | – | -33,997 | -100.0% | -0.01% | – |
ARDX | Exit | ARDELYX INC | $0 | – | -229,916 | -100.0% | -0.01% | – |
CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -356,804 | -100.0% | -0.01% | – |
IPHA | Exit | INNATE PHARMA S Asponsored ads | $0 | – | -79,896 | -100.0% | -0.01% | – |
CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -96,905 | -100.0% | -0.02% | – |
Exit | CORTEXYME INCput | $0 | – | -38,800 | -100.0% | -0.02% | – | |
LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -230,121 | -100.0% | -0.02% | – |
INSM | Exit | INSMED INC | $0 | – | -19,713 | -100.0% | -0.02% | – |
AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -123,416 | -100.0% | -0.02% | – |
PSTX | Exit | POSEIDA THERAPEUTICS INC | $0 | – | -89,886 | -100.0% | -0.02% | – |
Exit | COMPASS PATHWAYS PLCcall | $0 | – | -28,300 | -100.0% | -0.02% | – | |
Exit | DECIPHERA PHARMACEUTICALS INput | $0 | – | -65,700 | -100.0% | -0.02% | – | |
Exit | CARIBOU BIOSCIENCES INC | $0 | – | -41,932 | -100.0% | -0.02% | – | |
AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -197,130 | -100.0% | -0.02% | – |
IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -19,071 | -100.0% | -0.02% | – |
ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -48,266 | -100.0% | -0.02% | – |
ENVB | Exit | ENVERIC BIOSCIENCES INC | $0 | – | -742,046 | -100.0% | -0.02% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -4,872 | -100.0% | -0.03% | – |
NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -42,069 | -100.0% | -0.03% | – |
OYST | Exit | OYSTER PT PHARMA INC | $0 | – | -41,130 | -100.0% | -0.03% | – |
SPKBU | Exit | SILVER SPIKE ACQUISITN CORPunit 02/26/2026 | $0 | – | -77,505 | -100.0% | -0.03% | – |
Exit | KRYSTAL BIOTECH INCput | $0 | – | -12,100 | -100.0% | -0.03% | – | |
RDUS | Exit | RADIUS HEALTH INC | $0 | – | -124,607 | -100.0% | -0.03% | – |
OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -93,330 | -100.0% | -0.03% | – |
VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -21,685 | -100.0% | -0.03% | – |
Exit | ARYA SCIENCES ACQUISITN CORP | $0 | – | -98,980 | -100.0% | -0.04% | – | |
Exit | DECIPHERA PHARMACEUTICALS INcall | $0 | – | -98,200 | -100.0% | -0.04% | – | |
KOD | Exit | KODIAK SCIENCES INC | $0 | – | -12,115 | -100.0% | -0.04% | – |
CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -28,118 | -100.0% | -0.04% | – |
OMIC | Exit | SINGULAR GENOMICS SYSTEMS IN | $0 | – | -90,551 | -100.0% | -0.04% | – |
Exit | ROIVANT SCIENCES LTD | $0 | – | -104,413 | -100.0% | -0.04% | – | |
BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -13,978 | -100.0% | -0.04% | – |
Exit | BELLUS HEALTH INC NEWput | $0 | – | -141,700 | -100.0% | -0.04% | – | |
ABGI | Exit | ABG ACQUISITION CORP I | $0 | – | -116,070 | -100.0% | -0.04% | – |
DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -114,945 | -100.0% | -0.04% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.04% | – |
APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -433,859 | -100.0% | -0.04% | – |
KURA | Exit | KURA ONCOLOGY INC | $0 | – | -89,612 | -100.0% | -0.04% | – |
Exit | LUCIRA HEALTH INCcall | $0 | – | -147,800 | -100.0% | -0.05% | – | |
IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -48,544 | -100.0% | -0.05% | – |
SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -71,320 | -100.0% | -0.06% | – |
PMGMU | Exit | PRIVETERRA ACQUISITION CORPunit 99/99/9999 | $0 | – | -157,759 | -100.0% | -0.06% | – |
Exit | STRYVE FOODS INC | $0 | – | -437,551 | -100.0% | -0.06% | – | |
IMGN | Exit | IMMUNOGEN INC | $0 | – | -249,283 | -100.0% | -0.07% | – |
MRK | Exit | MERCK & CO INC | $0 | – | -24,246 | -100.0% | -0.07% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -24,361 | -100.0% | -0.08% | – |
Exit | ADAPTHEALTH CORPput | $0 | – | -98,600 | -100.0% | -0.09% | – | |
Exit | IMMUNOGEN INCcall | $0 | – | -325,000 | -100.0% | -0.09% | – | |
Exit | KODIAK SCIENCES INCput | $0 | – | -29,100 | -100.0% | -0.09% | – | |
BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -9,857 | -100.0% | -0.09% | – |
Exit | BAUSCH HEALTH COS INCcall | $0 | – | -98,600 | -100.0% | -0.10% | – | |
Exit | FATE THERAPEUTICS INCput | $0 | – | -48,500 | -100.0% | -0.10% | – | |
Exit | RAPID MICRO BIOSYSTEMS INC | $0 | – | -276,871 | -100.0% | -0.11% | – | |
Exit | ORGANOGENESIS HLDGS INCput | $0 | – | -345,000 | -100.0% | -0.12% | – | |
Exit | AXONICS INCput | $0 | – | -59,100 | -100.0% | -0.12% | – | |
Exit | IMMUNOGEN INCput | $0 | – | -484,600 | -100.0% | -0.13% | – | |
INCY | Exit | INCYTE CORP | $0 | – | -49,278 | -100.0% | -0.13% | – |
NKTR | Exit | NEKTAR THERAPEUTICSput | $0 | – | -283,576 | -100.0% | -0.14% | – |
Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -155,214 | -100.0% | -0.14% | – | |
Exit | ADAPTIVE BIOTECHNOLOGIES CORcall | $0 | – | -161,800 | -100.0% | -0.16% | – | |
Exit | MERCK & CO INCcall | $0 | – | -62,300 | -100.0% | -0.17% | – | |
RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -503,955 | -100.0% | -0.18% | – |
Exit | NANOSTRING TECHNOLOGIES INCcall | $0 | – | -118,600 | -100.0% | -0.18% | – | |
ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -510,507 | -100.0% | -0.18% | – |
Exit | ETF SER SOLUTIONSput | $0 | – | -246,400 | -100.0% | -0.19% | – | |
Exit | HOLOGIC INCput | $0 | – | -75,000 | -100.0% | -0.21% | – | |
Exit | MODERNA INCput | $0 | – | -23,200 | -100.0% | -0.21% | – | |
DNAY | Exit | CODEX DNA INC | $0 | – | -572,299 | -100.0% | -0.22% | – |
PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -330,033 | -100.0% | -0.24% | – |
Exit | SIGNIFY HEALTH INCput | $0 | – | -496,700 | -100.0% | -0.26% | – | |
Exit | INTUITIVE SURGICAL INCput | $0 | – | -20,000 | -100.0% | -0.26% | – | |
Exit | OMEGA HEALTHCARE INVS INCput | $0 | – | -246,400 | -100.0% | -0.26% | – | |
Exit | OAK STR HEALTH INCput | $0 | – | -231,600 | -100.0% | -0.28% | – | |
Exit | DELTA AIR LINES INC DELput | $0 | – | -197,100 | -100.0% | -0.28% | – | |
Exit | TELEFLEX INCORPORATEDput | $0 | – | -25,800 | -100.0% | -0.31% | – | |
Exit | IDEXX LABS INCput | $0 | – | -13,100 | -100.0% | -0.31% | – | |
PFE | Exit | PFIZER INC | $0 | – | -152,273 | -100.0% | -0.33% | – |
Exit | ARENA PHARMACEUTICALS INCput | $0 | – | -97,100 | -100.0% | -0.33% | – | |
Exit | ALCON AGput | $0 | – | -108,100 | -100.0% | -0.34% | – | |
Exit | DANAHER CORPORATIONput | $0 | – | -30,000 | -100.0% | -0.36% | – | |
Exit | NEOGENOMICS INCput | $0 | – | -295,700 | -100.0% | -0.36% | – | |
Exit | NUVASIVE INCput | $0 | – | -216,900 | -100.0% | -0.41% | – | |
Exit | OLAPLEX HLDGS INC | $0 | – | -399,906 | -100.0% | -0.42% | – | |
Exit | AMYRIS INCcall | $0 | – | -2,200,000 | -100.0% | -0.43% | – | |
QTRX | Exit | QUANTERIX CORP | $0 | – | -292,877 | -100.0% | -0.45% | – |
Exit | SOUTHWEST AIRLS COput | $0 | – | -295,700 | -100.0% | -0.46% | – | |
Exit | PERKINELMER INCput | $0 | – | -69,600 | -100.0% | -0.51% | – | |
DXCM | Exit | DEXCOM INC | $0 | – | -26,312 | -100.0% | -0.51% | – |
SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -596,981 | -100.0% | -0.52% | – |
Exit | COOPER COS INCput | $0 | – | -39,500 | -100.0% | -0.60% | – | |
Exit | AMN HEALTHCARE SVCS INCcall | $0 | – | -150,000 | -100.0% | -0.66% | – | |
Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -97,000 | -100.0% | -0.77% | – | |
NTRA | Exit | NATERA INC | $0 | – | -235,199 | -100.0% | -0.80% | – |
Exit | DEXCOM INCput | $0 | – | -43,300 | -100.0% | -0.84% | – | |
Exit | ARENA PHARMACEUTICALS INCcall | $0 | – | -291,100 | -100.0% | -0.98% | – | |
Exit | SELECT SECTOR SPDR TRput | $0 | – | -400,000 | -100.0% | -2.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.